In this review:
Murine model demonstrates survival benefit with dual inhibition of JAK and MCL-1
Predictors of early relapse in transplant-eligible patients
Treatment induced cytotoxic T cell modulation
CARTITUDE-1 results of CAR-T therapy in heavily pre-treated patients
Elotuzumab stimulates adaptive immunity by selective phagocytosis of immunosuppressive T cells
Could tandem transplant improve outcomes in high-risk patients?
ASCT in patients with MM and impaired renal function
Application of risk models for smoldering MM to a real-world cohort
Cost effectiveness of novel agents
On-demand plerixafor for hematopoietic stem-cell mobilization
Please login below to download this issue (PDF)